|
Market Closed -
Other stock markets
|
After hours 04:45:30 am | |||
| 250.00 EUR | +0.52% |
|
249.95 | -0.02% |
| 02:46pm | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
| 03/07 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
| Market Cap | 47.34B 54.12B 43.66B 40.39B 76.67B 5,166B 77.95B 523B 205B 2,537B 203B 199B 8,787B | P/E 2026 * |
26.8x | P/E 2027 * | 21.1x |
|---|---|---|---|---|---|
| Enterprise Value | 47.07B 53.81B 43.41B 40.16B 76.23B 5,136B 77.51B 520B 204B 2,522B 202B 198B 8,736B | EV / Sales 2026 * |
5.52x | EV / Sales 2027 * | 4.67x |
| Free-Float |
61.59% | Yield 2026 * |
0.59% | Yield 2027 * | 0.61% |
Last Transcript: UCB
| 1 day | +0.52% | ||
| 1 week | -5.52% | ||
| Current month | -4.58% | ||
| 1 month | -4.69% | ||
| 3 months | -8.02% | ||
| 6 months | -1.88% | ||
| Current year | +4.78% |
| 1 week | 247.3 |  | 265.2 |
| 1 month | 243.3 | | 275.5 |
| Current year | 223 | | 289.5 |
| 1 year | 168.45 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/01 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 15/01 | Buy | Director | 500 | 0.0003% | ||
| 15/01 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.52% | -5.52% | +46.80% | +218.71% | 53.98B | |
| +0.42% | +1.95% | +20.71% | -5.17% | 67.44B | |
| -2.79% | +32.50% | +32.50% | +32.50% | 41.77B | |
| +0.99% | +6.05% | -48.96% | -52.97% | 41.15B | |
| -0.46% | -7.57% | +50.17% | -29.06% | 29.58B | |
| +2.78% | -5.28% | +130.41% | -38.62% | 29.28B | |
| +0.67% | +1.20% | +72.09% | +91.08% | 23.43B | |
| +0.17% | +8.48% | +4.86% | +185.45% | 19.11B | |
| +1.14% | -0.17% | +68.83% | +134.48% | 16.82B | |
| +17.12% | +19.32% | +100.30% | +430.53% | 15.36B | |
| Average | +2.09% | +1.68% | +47.77% | +96.69% | 33.79B | |
| Weighted average by Cap. | +1.05% | +1.23% | +38.61% | +68.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.75B 7.87B 7.28B 13.82B 931B 14.05B 94.24B 36.94B 457B 36.62B 35.83B 1,584B | 9.63B 11.01B 8.88B 8.22B 15.6B 1,051B 15.86B 106B 41.71B 516B 41.35B 40.45B 1,788B |
| Net income | 1.75B 2B 1.61B 1.49B 2.83B 191B 2.88B 19.3B 7.56B 93.63B 7.5B 7.34B 324B | 2.26B 2.59B 2.09B 1.93B 3.67B 247B 3.73B 25B 9.8B 121B 9.71B 9.5B 420B |
| Net Debt | -271M -310M -250M -231M -439M -29.6B -447M -3B -1.17B -14.54B -1.16B -1.14B -50.35B | -2.31B -2.64B -2.13B -1.97B -3.75B -252B -3.81B -25.54B -10.01B -124B -9.93B -9.71B -429B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | EUR 250.00 | +0.52% | 266,649 |
| 08/07/26 | EUR 248.70 | -2.01% | 303,577 |
| 07/07/26 | EUR 253.80 | -0.24% | 242,415 |
| 06/07/26 | EUR 254.40 | -1.97% | 169,111 |
| 03/07/26 | EUR 259.50 | -1.93% | 131,923 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
